NEW YORK (GenomeWeb News) — Metabolon said yesterday that the US Army Medical Research Institute of Infectious Diseases will use its metabolomics platform to study the effects of the AVA anthrax vaccine in humans.
 
Metabolon's chief science officer Mike Milburn said the collaboration on the FDA-approved vaccine is the “first large-scale metabolomics study of human subjects given a vaccine.”
 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In an against-all-odds twist, a researcher studying exceeding rare FOXG1 mutations discovers her daughter has the syndrome.

An effort by Genomics Medicine Ireland is creating a database of diseases based on the genomics of people in Ireland. It now is looking into the possibility of including Scotland in its work.

In recent weeks, the direct-to-consumer genetics firm has rolled out a health hub where customers can share information concerning 18 common health conditions.

In PLOS this week, new genes associated with prostate cancer risk, genetic patterns in M. bovis, and more.